|
1
|
Correa P: Gastric cancer: Overview.
Gastroenterol Clin North Am. 42:211–217. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol:
Jul 3, 2017 (Epub ahead of print). doi:
10.1177/1010428317714626.
|
|
3
|
Wu H, Wang W, Tong S and Wu C:
Nucleostemin regulates proliferation and migration of gastric
cancer and correlates with its malignancy. Int J Clin Exp Med.
8:17634–17643. 2015.PubMed/NCBI
|
|
4
|
Chen S, Zhang Q, Wu X, Schultz PG and Ding
S: Dedifferentiation of lineage-committed cells by a small
molecule. J Am Chem Soc. 126:410–411. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hsieh TC, Traganos F, Darzynkiewicz Z and
Wu JM: The 2,6-disubstituted purine reversine induces growth arrest
and polyploidy in human cancer cells. Int J Oncol. 31:1293–1300.
2007.PubMed/NCBI
|
|
6
|
Lu YC, Lee YR, Liao JD, Lin CY, Chen YY,
Chen PT and Tseng YS: Reversine induced multinucleated cells, cell
apoptosis and autophagy in human non-small cell lung cancer cells.
PLoS One. 11(e0158587)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kuo CH, Lu YC, Tseng YS, Shi CS, Chen SH,
Chen PT, Wu FL, Chang YP and Lee YR: Reversine induces cell cycle
arrest, polyploidy, and apoptosis in human breast cancer cells.
Breast Cancer. 21:358–369. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jemaa M, Abassi Y, Kifagi C, Fezai M,
Daams R, Lang F and Massoumi R: Reversine inhibits colon carcinoma
cell migration by targeting JNK1. Sci Rep. 8(11821)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Park YL, Ha SY, Park SY, Choi JH, Jung MW,
Myung DS, Kim HS and Joo YE: Reversine induces cell cycle arrest
and apoptosis via upregulation of the Fas and DR5 signaling
pathways in human colorectal cancer cells. Int J Oncol.
54:1875–1883. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu X, Liao W, Yuan Q, Ou Y and Huang J:
TTK activates Akt and promotes proliferation and migration of
hepatocellular carcinoma cells. Oncotarget. 6:34309–34320.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kaistha BP, Honstein T, Muller V, Bielak
S, Sauer M, Kreider R, Fassan M, Scarpa A, Schmees C, Volkmer H, et
al: Key role of dual specificity kinase TTK in proliferation and
survival of pancreatic cancer cells. Br J Cancer. 111:1780–1787.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
King JL, Zhang B, Li Y, Li KP, Ni JJ,
Saavedra HI and Dong JT: TTK promotes mesenchymal signaling via
multiple mechanisms in triple negative breast cancer. Oncogenesis.
7(69)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang J, Xie Y, Bai X, Wang N, Yu H, Deng
Z, Lian M, Yu S, Liu H, Xie W and Wang M: Targeting dual
specificity protein kinase TTK attenuates tumorigenesis of
glioblastoma. Oncotarget. 9:3081–3088. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ahn CH, Kim YR, Kim SS, Yoo NJ and Lee SH:
Mutational analysis of TTK gene in gastric and colorectal cancers
with microsatellite instability. Cancer Res Treat. 41:224–228.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Finetti P, Cervera N, Charafe-Jauffret E,
Chabannon C, Charpin C, Chaffanet M, Jacquemier J, Viens P,
Birnbaum D and Bertucci F: Sixteen-kinase gene expression
identifies luminal breast cancers with poor prognosis. Cancer Res.
68:767–776. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hudler P, Britovsek NK, Grazio SF and
Komel R: Association between polymorphisms in segregation genes
BUB1B and TTK and gastric cancer risk. Radiol Oncol. 50:297–307.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang YW, Zhu ZG, Liu BY, Gu QL, Li JF, Qu
Y, Chen XH and Lin YZ: Expression and clinical significance of
cancer-related gene MPS-1 in gastric cancer. Zhonghua Wei Chang Wai
Ke Za Zhi. 8:503–506. 2005.PubMed/NCBI(In Chinese).
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pikir BS, Susilowati H, Hendrianto E and
Abdulrantam F: Reversin increase the plasticity of bone
marrow-derived mesenchymal stem cell for generation of
cardiomyocyte in vitro. Acta Med Indones. 44:23–27. 2012.PubMed/NCBI
|
|
20
|
Lee EK, Bae GU, You JS, Lee JC, Jeon YJ,
Park JW, Park JH, Ahn SH, Kim YK, Choi WS, et al: Reversine
increases the plasticity of lineage-committed cells toward
neuroectodermal lineage. J Biol Chem. 284:2891–2901.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cheng L, Wang H, Guo K, Wang Z, Zhang Z,
Shen C, Chen L and Lin J: Reversine, a substituted purine, exerts
an inhibitive effect on human renal carcinoma cells via induction
of cell apoptosis and polyploidy. Onco Targets Ther. 11:1025–1035.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Llambi F and Green DR: Apoptosis and
oncogenesis: Give and take in the BCL-2 family. Curr Opin Genet
Dev. 21:12–20. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jemaà M, Galluzzi L, Kepp O, Boileve A,
Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia
A, et al: Preferential killing of p53-deficient cancer cells by
reversine. Cell Cycle. 11:2149–2158. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Huang H, Wu K, Ma J, Du Y, Cao C and Nie
Y: Dopamine D2 receptor suppresses gastric cancer cell invasion and
migration via inhibition of EGFR/AKT/MMP-13 pathway. Int
Immunopharmacol. 39:113–120. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lyu Y, Xiao Q, Yin L, Yang L and He W:
Potent delivery of an MMP inhibitor to the tumor microenvironment
with thermosensitive liposomes for the suppression of metastasis
and angiogenesis. Signal Transduct Target Ther.
4(26)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen S, Wang J, Wang L, Peng H, Xiao L, Li
C, Lin D and Yang K: Silencing TTK expression inhibits the
proliferation and progression of prostate cancer. Exp Cell Res.
385(111669)2019.PubMed/NCBI View Article : Google Scholar
|
